CNBC: Mad Money
5/6/2024 10:33pm
... the cgen is starting to kick in. i think they're doing a lot of stuff by the way, with migraine, which makes me happy being a spokesperson for the american migraine foundation. i don't want to call it a new pfizer, i want to call it an energized pfizer. ...
CNBC: Mad Money
5/6/2024 10:33pm
... how about you? doing good. thank you. my question is about pfizer, i chose that as a holding versus moderna during the operation, is pfizer going to be a sleeper? i think pfizer is bottoming. ...
FOX Business: The Evening Edit
5/6/2024 10:00pm
... when think it really bothers me and concerns me is the fact that is a compensation program for vaccine injury and why is a covid-19 included that and that needs to change. liz: i hope the government this is who you any congress should call you and you testified did not meet it with the schedule ...
FOX Business: The Evening Edit
5/6/2024 10:00pm
... example just as we do on antibiotics or cigarette boxes and is important that we take responsibility to make sure that we inform the public so that we stop causing these possibly preventable vaccine injuries ...
CNBC: Mad Money
5/6/2024 10:00pm
... dan? yeah, pfizer breaking out above an epic downtrend. bonawyn? i'm with guy, i'm with carter, xle. steve grasso? west rock. wrk, breaking out. happy birthday, tim. anyofor watching 'fast ...
CNBC: Fast Money
5/6/2024 10:00pm
... deputy bureau chief laura batram making it happen. happy birthday, tim seymour. ali baba, melms. dan? yeah, pfizer breaking out above an epic downtrend. bonawyn? i'm with guy, i'm with ...
FOX Business: The Evening Edit
5/6/2024 10:00pm
... injuries and patients don't realize don't know what you be from is important that we understand that anything that we adjuster come into contact with the vaccine her medication, you have a potential side effect black box warnings vaccines for ...
FOX Business: The Evening Edit
5/6/2024 9:59pm
... government is ignoring them why and listen we understand how the vaccine worked sopping covid-19 the people were also making unhealthy choices not getting covid-19 and wise government ignoring these people. we know, this immoral and ...
FOX Business: The Evening Edit
5/6/2024 9:59pm
... patients not just hide it under the rug. liz: so these intolerant moralizing bullies you know they act like they are so open-minded with her braids have fallen out of the backs of their hats and so those injured on the covid-19 vaccine new york times of the ...
FOX Business: The Evening Edit
5/6/2024 9:58pm
... americans received at least one dose of the covid-19 vaccine there been more than 1 million reports and there's the vaccine adverse events reporting system for the cdc is only claiming few ...
FOX Business: The Evening Edit
5/6/2024 9:57pm
... men and first responders and nurses people for lines it was putting their lives on the line yet they were punished in the lost jobs because they refused to take a vaccine with refused to take certain medications itself there should be a definite learning lesson they ...
FOX Business: The Evening Edit
5/6/2024 9:57pm
... anyone questioning the safety of vaccines the covid-19 vaccine demanding the passport now near times reports that thousands literally thousands they'll say that vaccine injured them you notice a deafening silence ...
FOX Business: The Evening Edit
5/6/2024 9:52pm
... covid-19 vaccines and more reports show those who doubted these vaccines are being proved right doctor jeanette will break it down next month evening at it. ...
FOX Business: The Evening Edit
5/6/2024 9:52pm
... physically injured and wounded from the covid-19 vaccine and healthpro stellar slamming the intolerant bullies attack and shame were down those who questioned the safety of ...
FOX Business: The Evening Edit
5/6/2024 9:18pm
... tell your doctor if you have an infection or symptoms, had a vaccine or plan to, or if ibd symptoms develop or worsen. it's good to be moving on. watch me. move, look, and feel better. ask your rheumatologist about cosentyx. ...
FOX Business: The Evening Edit
5/6/2024 9:13pm
... questioning the safety of covid-19 vaccines and look at this, the new york times reports that thousand say that covid-19 vaccines injured and wounded them and plus families and students are fed up near protesters disrupting graduation ...
FOX Business: Varney Company
5/6/2024 1:15pm
... and an increased risk of infections, some fatal, have occurred. tell your doctor if you have an infection or symptoms, had a vaccine or plan to, or if ibd symptoms develop or worsen. it's good to be moving on. watch me. move, look, and feel better. ...
FOX Business: Barrons Roundtable
5/5/2024 1:49pm
... some fatal, have occurred. tell your doctor if you have an infection or symptoms, had a vaccine or plan to, or if ibd symptoms develop or worsen. still workin' for me. see me. it's been a rocky month for stocks all major industries down ...
FOX Business: Maria Bartiromos Wall Street
5/4/2024 1:20pm
... have a 4 times higher risk for psoriatic arthritis. serious allergic reactions, severe skin reactions that look like eczema, and an increased risk of infections, some fatal, have occurred. tell your doctor if you have an infection or symptoms, had a vaccine or plan to, or if ibd symptoms develop or ...
FOX Business: Maria Bartiromos Wall Street
5/4/2024 1:20pm
... or symptoms, had a vaccine or plan to or if ibd symptoms develop or worsen. see me i couldn't get my hair done. then psoriatic arthritis. cosentyx works on both for me. people with psoriasis on the scalp ...
FOX Business: Maria Bartiromos Wall Street
5/4/2024 1:19pm
... or symptoms, had a vaccine or plan to or if ibd symptoms develop or worsen. see me my psoriasis was all over. then psoriatic arthritis. who knew they could be connected? for me, cosentyx works on both. ...
FOX Business: The Evening Edit
5/3/2024 9:40pm
... makary on the new york times paying attention to vaccination from covid, side effects, injuries, illnesses. we dig in top of the hour. an el, tailor-made for trader minds. ...
CNBC: The Exchange
5/3/2024 5:17pm
... johnson & johnson who told us it would take ten years to come up with a vaccine like polio. it took a year it turns out. so i think you'll see that acceleration in many areas, including cancer treatment. you could very well see that in ...
CNBC: The Exchange
5/3/2024 5:17pm
... to broaden out over just weight loss and obesity? we believe it is. if you look at the new technology that led to the covid vaccine, you know, we were talking to a senior person at ...
CNBC: The Exchange
5/3/2024 5:16pm
... decrease in terms of yield, given the rates on pharmaceuticals get to be more appealing and hopefully eventually there is vaccine technologies that start to kick in, which we expect to happen in the next year or so. people haven't been talking about vaccines when it comes to ...
CNBC: Squawk on the Street
5/3/2024 1:52pm
... take a look at week-to-date nasdaq 100 gainers. tesla in there, moderna, amgen, not just helping the ndx but that and apple adding about 350 points to this 500-point d gain. take a short break here and be ...
CNBC: Squawk on the Street
5/3/2024 1:33pm
... brinker, put in, is there anything new with brinker? i think it was bancel from moderna where 60% of workers there are using chatgpt or some variation of a.i. i don't know how you don't ...
CNBC: Squawk on the Street
5/3/2024 1:31pm
... stocks that are suddenly in the conversation again. and i think it's important to point out that pfizer may have some momentum too. yeah, huge weight in the dow, even before the jobs number was going to account for a couple hundred points of gain. sure, and obviously, the treasurys are signaling ...
CNBC: Squawk on the Street
5/3/2024 1:30pm
... they have a terrific migraine drug that is not getting its due. and all i can tell you is that they're a juggernaut that people don't think is a juggernaut, and their dow stock that everyone was unexcited about, but they and pfizer are the two drug ...
FOX Business: The Claman Countdown
5/2/2024 7:23pm
... only shingrix is proven over 90% effective. shingrix is a vaccine used to prevent shingles in adults 50 years and older. shingrix does not protect everyone and is not for those with severe allergic reactions to its ingredients or to a previous dose. an increased risk of guillain-barré syndrome was ...
CNBC: Closing Bell
5/2/2024 7:22pm
... even though sales were its covid vaccine fell by 91% from one year ago. the company reiterating its full sales guidance as experts covid sales to pick up in the ...
CNBC: Closing Bell
5/2/2024 7:22pm
... and earnings and guidance. for the job cuts worldwide as part of restructuring effort. lastly, the ceo stepping down. the board will continue research to replace them. for is not turned a profit since december 2020. it carries $1 billion in debt. and moderna is posting a smaller loss. ...
CNBC: Fast Money Halftime Report
5/2/2024 4:24pm
... you have a lot of great ideas. you don't need to own pfizer full disclosure, it's a total return story now so, no, i'm not going to sell it i've owned it for ten years in that portfolio ...
CNBC: Fast Money Halftime Report
5/2/2024 4:22pm
... acquisition, and i don't think there's enough enthusiasm for how many patents them acquired and how many fda approvals they have or will continue to get and that, for me, if you are a shareholder of pfizer now, what you want to focus on the stock is up 10% over the last week, down 4% year to date. ...
CNBC: Fast Money Halftime Report
5/2/2024 4:22pm
... the worst performers in the market, and everyone on earth is aware of the reason why. they made a huge bet on covid between paxlovid and the vaccines, and that bet proved to have been not something that was going to sustain growth past ...
CNBC: Fast Money Halftime Report
5/2/2024 4:21pm
... you've doubled down. what did i say? the most attractive stock? i said that? yeah. i want to up the rhetoric one of the most mispriced securities i will tell you why. we're now in a situation with pfizer where there is nobody ...
CNBC: Fast Money Halftime Report
5/2/2024 4:21pm
... me, that's the thing that can get the stock out of the range, to answer your question. another stock, before we take our first break, courtesy of josh pfizer you said was the most attractive in the market and ...
FOX Business: Varney Company
5/2/2024 2:29pm
... what about come to market, the fall target date for the launch of their rsv shot and also posted to than expected fiscal results. stuart: i thought vaccines were falling out of favor, all vaccines. lauren: the mra in a vaccine is ...
FOX Business: Varney Company
5/2/2024 2:29pm
... stuart: an hour into the trading session, the pickup for the dow up one hundred 50 points, nasdaq up 85, lauren is looking at the movers and we better start with moderna. lauren: up 8%, no one is getting the covid shot, not ...
CNBC: Squawk Box
5/2/2024 12:20pm
... invented, discovered the vaccine. and the single biggest reason a lot of things we're still working on in this country. all right got to get the college stuff under control. do you think president biden ought to, you know, get out there and lead us morally on this it's ard, i guess, but -- we ...
Bloomberg: Bloomberg Surveillance
5/2/2024 11:48am
... thinking about the pandemics, -- we were talking with the ceo of moderna. it worked. under surveillance this morning chair powell staying true to form. i think there's a lot of ...
Bloomberg: Bloomberg Surveillance
5/2/2024 11:43am
... about the efforts taking place at moderna. trying to bring up sex and the city with the modernity ceo. you want to spring carrie bradshaw into the conversation. when i was a kid i didn't have the tv. ...
Bloomberg: Bloomberg Surveillance
5/2/2024 11:38am
... vaccines. you have this melanoma vaccine in the works, what more do you have to do to get it set up for the approval process to apply, are you using artificial intelligence to expedite that? stephane: if you look at cancer ...
Bloomberg: Bloomberg Surveillance
5/2/2024 11:38am
... if vaccines have a good t cell response i'm not worried that all about duration. pretty much every time we speak i ask you have weaker cured cancer yet. it's been one of the big questions, the hope for the mrna ...
Bloomberg: Bloomberg Surveillance
5/2/2024 11:37am
... duration of vaccination is induced and if you look at the cancer product the only reason it works is t cells, not antibodies. they are going and attacking the cancer. ...
Bloomberg: Bloomberg Surveillance
5/2/2024 11:37am
... whether that's questioned by the promise of your net -- technology. if you look at the data they are very similar so i don't think it's correct to say one of the vaccines doesn't last as ...
Bloomberg: Bloomberg Surveillance
5/2/2024 11:35am
... opportunities we announce we are stopping and search in the team. if you look at the portfolio we are looking at all investments and a thing about those vaccines ...
Bloomberg: Bloomberg Surveillance
5/2/2024 11:35am
... cost-cutting offsetting a steep decline which they were expecting to receive. an rsv vaccine in the coming days. wonderful to catch up with you. the stock is just about positive in the premarket. ...
CNBC: Squawk Box
5/2/2024 11:01am
... cancer, and lung cancer. we believe there is a lot of data demonstrating the fplatform of our vaccine treatment is working across many. we're going to go higher response rate because of technology works by leveraging ...
CNBC: Squawk Box
5/2/2024 11:00am
... late 2020s a few years because we have a lot of vaccines that we're going to be launching. if you think about the numbers between the covid sales and then rsv and flu plus covid, flu is three times the size of covid ...
CNBC: Squawk Box
5/2/2024 11:00am
... vaccines are finally developed, assuming that you're successful and that they, you know, that it is actually a viable way to treat such a horrific disease? when do you see that being the lion's share of revenue? ...
CNBC: Squawk Box
5/2/2024 11:00am
... you talk about the vaccine program, there are myriad things besides covid, obviously rsv, other things that can bridge or have a bridge for you. between that, do you view that as a bridge to when the cancer ...
CNBC: Squawk Box
5/2/2024 10:59am
... we'll be presenting the survival data which we have top line in december i guess you called on oncology because there are cancer vaccines. ...
CNBC: Squawk Box
5/2/2024 10:59am
... is coming together very nicely and in '24, '25, '26, '27, every year you'll see multiple vaccine launches which will help tremendously and all going from different opportunities. ...
CNBC: Squawk Box
5/2/2024 10:59am
... potentially as of this spring. and then you have the fall, we recently have new data on the evb being positive so i think the vaccine platform ...
CNBC: Squawk Box
5/2/2024 10:59am
... we are -- the launch very soon this spring. we're going to get the combo, the vaccine with covid and flu in the single dose, we should get the data very soon, ...
CNBC: Squawk Box
5/2/2024 10:58am
... around $800 million of opex across manufacturing i think we have done a great job within the company what i'm more excited about is the future, which is we have an amazing vaccine platform ...
CNBC: Squawk Box
5/2/2024 10:57am
... and i just wanted to encapsulate how difficult a post pandemic, you know, when you had such an incredible run, because of the vaccines, this is just, you know, a fact of living in this ...
CNBC: Squawk Box
5/2/2024 10:57am
... moderna ceo. and, i don't know if that really summarizes the daunting task that you've been facing, stephane there is worse things in the world. you have a great company, doing amazing things i didn't compare the results -- _ ...
CNBC: Squawk Box
5/2/2024 10:56am
... you're watching the shares of moderna, the company reported results moments ago, smaller than expected loss revenue was above forecasts, though down from a year ago, as covid vaccine sales fell joining us now, stephane bancel, ...
CNBC: Squawk Box
5/2/2024 10:35am
... pfizer and moderna since the pandemic ended that is true. meantime, closing arguments today in the government's anti-trust case against google let's get to eamon javers in washington with the latest on that case, eamon ...
CNBC: Squawk Box
5/2/2024 10:34am
... moderna earnings a loss of $3.07 a share. smaller than the loss of $3.58 ...
CNBC: Street Signs
5/2/2024 8:18am
... that look like eczema, and an increased risk of infections, some fatal, have occurred. tell your doctor if you have an infection or symptoms, had a vaccine or plan to, or if ibd symptoms develop or worsen. still workin' for me. see me. ...
CNBC: Mad Money
5/1/2024 10:10pm
... call is on. i don't see anything in the hopper it feels like pfizer. let's go to max who's in illinois. max. jimbo. how's it going? ...
CNBC: Fast Money
5/1/2024 10:00pm
... about j&j, but pfizer. going higher karen yes morgan stanley and also hello to a longtime watcher, gavin. steve i went with the ipo today, viking holdings, and i'm going to go see michael on sunday up ...
FOX Business: The Evening Edit
5/1/2024 9:49pm
... vaccines did work, but they were emergency use vaccines, they were off the shelf, they were unproven, untested. they're found to cause thrombosis, myocarditis, cardiomyopathy and more. that's a real problem for the american people that they were ...
FOX Business: The Evening Edit
5/1/2024 9:49pm
... to restrict, you know, any books about the covid-19 vaccine. you know, by the way, where did all the dangerous variants to? i mean, there was all this news that dangerous variants were going to swamp america. where'd it go? we understand that, yes, ...
FOX Business: The Evening Edit
5/1/2024 9:48pm
... congressman, your to that report. okay, people feel lied to, betrayed and misled that the government prevented them from knowing the dangerous side effects of covid vaccines that can cause heart, brain and other organ injuries, also, you know, ...
FOX Business: The Evening Edit
5/1/2024 9:47pm
... false information about vaccines or covid at large during this time period? no. mr. flaherty, same question. i can't recall. and, of course, both of you were doing all of this to save lives, weren't you? yes. yes. ...
FOX Business: The Evening Edit
5/1/2024 9:46pm
... facing questions from republicans. rob flaherty and director of digital strategy wouldn't admit when asked if any of the vaccine narrative pressed by the biden team turned out to be misleading. when the biden administration ...
FOX Business: The Evening Edit
5/1/2024 9:45pm
... information about how dangerous covid vaccines are. this new development, astrazeneca revealed in court documents its vaccine does trigger rare blood clots. that's the covid vaccine. it also triggers low platelet ...
FOX Business: The Evening Edit
5/1/2024 9:39pm
... mark theseen, thank you so much. still ahead, house ways and means chair jason smith. lawmakers gave a tough grilling to former biden white house officials. they were accused of censoring information on how dangerous covid vaccines were. you went through that. ...
CNBC: Fast Money
5/1/2024 9:24pm
... neither j&j or pfizer are playing in that obesity area, and that's what's hot right now. all right coming up, earnings season rolls on, and we've got a lot more action to bring you, in shares of zillow, doordash, and mgm ...
CNBC: Fast Money
5/1/2024 9:24pm
... rates have gone down drastically after we've gotten a couple years away from the pandemic so, they have to come up with -- even though they're a great company, they have a lot of other things, it was vaccine for them that really moved the needle now, they have to come up with something to replace ...
CNBC: Fast Money
5/1/2024 9:24pm
... earnings call. where do you stand on some of these? both charts look similar. i owned pfizer for a long time, i don't own it any longer. i think once you got through the pandemic, it became, as we saul know on the desk, a vaccine story. you don't have to be an anti-vaxer to see that vaccine ...
CNBC: Fast Money
5/1/2024 9:23pm
... your pfizer/your j&j, too. yeah, i own both names. and that's a very -- you know, i haven't really felt that beleaguered in j&j, and i've owned for it, i don't know, six months, ish, and the view is the ...
CNBC: Fast Money
5/1/2024 9:22pm
... because you may not always see yourself in the world, but we see you. welcome back to 'fast money. two pharma giants topping the tape today, though for different reasons. pfizer up 6% after beating e earnings expectations. ...
CNBC: Fast Money
5/1/2024 9:01pm
... plus, sinking starbucks, dropping 18% at the lows of the day. the ceo getting into a testy exchange this morning. is there any reason to be bullish on this stock? we'll talk to one analyst. and later, pfizer shares catch a bid after earnings ...
FOX Business: The Claman Countdown
5/1/2024 7:53pm
... stopping. liz: albert bourla of pfizer, thank you very and have we look forward to following the story and the stock is up 6.5% and very close to session highs at the moment. thank you so much. thank you. liz: wall street in a per ma bull mode with executives ...
FOX Business: The Claman Countdown
5/1/2024 7:51pm
... what is the answer and how integral is pfizer in trying to help the situation in this country and somehow shake the log jam for people to get hands on life-saving drugs? ...
FOX Business: The Claman Countdown
5/1/2024 7:51pm
... or may not be an issue at pfizer and issue nationally and that's the shortage of chemotherapy drugs and there's a sad story of beloved high school coach who died because he couldn't get his hands on chemotherapy drugs. ...
FOX Business: The Claman Countdown
5/1/2024 7:50pm
... the next development plans for approaching this molecule and emphasizing that pfizer will play is significant role in the ...
FOX Business: The Claman Countdown
5/1/2024 7:49pm
... many of our viewer's ears at the moment, albert, and props to wonderful people at pfizer and i know how hard they work over years to develop these kinds of drugs and we followed your company for a long, long time and you look at pharma world, ...
FOX Business: The Claman Countdown
5/1/2024 7:47pm
... covcovid-19 packs loved d -- paxlovid and pfizer's fumbles are now in the rear-view mirror. get to the growth story and future of pfizer with ceo albert ...
FOX Business: The Claman Countdown
5/1/2024 7:46pm
... recorded a rouge surprise bead in quarter profits and enough for investors to forgive a 20% dip in revenue. pfizer attributed the beat to extremely effective cost cutting measures as well as much smaller than expected dip in sails farce ...
FOX Business: The Claman Countdown
5/1/2024 7:41pm
... exclusive we're joined live by the pfizer ceo and only seeing him on 'claman countdown,' count go away. dow now up 222. we're coming right back. ...
FOX Business: The Claman Countdown
5/1/2024 7:41pm
... 20 minutes to trade and profit beat and optimistic guidance with sales stumbling year over year and what does pfizer have in the pipeline and going how far. coming up in a fox business ...
FOX Business: The Claman Countdown
5/1/2024 7:40pm
... outlook and medical costs in the insurance business to impact operations for the rest of the year. the good one and pfizer's latest earnings report triggered a real turn around in the stock at this hour. looking healthy and hardy with ...
CNBC: Fast Money Halftime Report
5/1/2024 4:57pm
... i want to be able to keep my plans. i don't want to risk ending up in the hospital with pneumococcal pneumonia. that's why i chose prevnar 20®. ask your doctor or pharmacist about the pfizer vaccine for pneumococcal pneumonia. () _ ...
CNBC: Fast Money Halftime Report
5/1/2024 4:57pm
... in just one dose. don't get prevnar 20® if you've had a severe allergic reaction to the vaccine or its ingredients. adults with weakened immune systems may have a lower response to the vaccine. the most common side effects were pain and swelling at the injection site, muscle pain, fatigue, ...
CNBC: Fast Money Halftime Report
5/1/2024 4:56pm
... () i'm getting vaccinated with pfizer's pneumococcal pneumonia vaccine. so am i. because i'm at risk for pneumococcal pneumonia. come on. i already got a pneumonia vaccine, but i'm asking about the added protection of prevnar 20®. ...
CNBC: Fast Money Halftime Report
5/1/2024 4:38pm
... there's you know what to pay the next time they're on the show. in all seriousness, pfizer, staying in the space, they beat the stock, raised utlook, as well right so you know, it's -- it's the same investment, the same argument that i've had all along is they just need to get past the covid ...
CNBC: Fast Money Halftime Report
5/1/2024 4:34pm
... check in on health care. ppg,is plunging, pfizer is poin and joe is selling a big name in that space we debate it all next. that's right james, it isn't. car, where are we going? ...
Bloomberg: Bloomberg Markets
5/1/2024 2:30pm
... nordisk the huge gains over the last few years. novo nordisk up 200%. eli lilly up more than 300%. not as much for astrazeneca. pfizer is down although they did ...
CNBC: Squawk on the Street
5/1/2024 2:26pm
... check out shares of pfizer today, cost cuts, strong non-covid sales and results benefitting from a smaller than feared drop in sales from the ...
Bloomberg: Bloomberg Markets
5/1/2024 2:26pm
... products. pfizer trying to regain their footing after the rapid decline of its covid business. finally playing catch-up. the maker of heinz ketchup and kraft mac & cheese says man for ...
Bloomberg: Bloomberg Markets
5/1/2024 2:25pm
... katie: time for social climbers. look at the stocks making waves on social media. pfizer leading expectations and hiking its full-year profit outlook. the defendant from cost cuts and strong sales of non-covid ...
CNBC: Squawk on the Street
5/1/2024 1:42pm
... which is still in a difficult situation, but i like the fact that j&j is closer and closer. i do think we're going to start seeing better numbers from pfizer i don't like the fact that these people of mine that the government prevailed in these ...
CNBC: Squawk on the Street
5/1/2024 1:41pm
... vaccine? right i know they did, guys, raise diluted -- adjusted diluted eps guidance, 215 to 235 and again, you're seeing a positive reaction in the overall ...
CNBC: Squawk on the Street
5/1/2024 1:41pm
... no. but the seagen acquisition, too early, right too early it is do you think he went to china and offered his vaccine to president xi, and president xi said, no, and that his vaccine was not as good as their ...